Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002308272 | SCV002601966 | likely pathogenic | Glycogen storage disease, type II | 2022-03-14 | criteria provided, single submitter | clinical testing | NM_000152.3(GAA):c.1814delG(G605Afs*91) is expected to be pathogenic in the context of Pompe disease. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in GAA, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |